Competitive landscape
Drugs aimed at the same indication, from approved to preclinical.
1 drug for “PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC”
Phase 3 1
- AcasunlimabGENMAB A/SPD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or Metastatic NSCLC
Drugs whose recorded indications name this term, by development stage. Indications come from registries and labels, so a drug can appear under related terms.